Alcatel Lucent : -Lucent and -Lucent USA Inc. announce results of -Lucent USA Inc. tender offer process under terms announced on 31 July 2015

Alcatel-Lucent and Alcatel-Lucent USA Inc. announce results of Alcatel-Lucent USA Inc. tender offer process under terms announced on 31 July 2015

Paris, France, September 2, 2015 - Alcatel-Lucent (Euronext Paris and NYSE: ALU) has announced today that its wholly-owned subsidiary Alcatel-Lucent USA Inc. (the "Company") has accepted for purchase an aggregate principal amount of $300,000,000 of its outstanding $1,000,000,000 6.750% Senior Notes due 2020 (the "Notes") pursuant to its offer to purchase for cash (the "Tender Offer") upon the terms and subject to the conditions set forth in the Offer to Purchase dated 31 July 2015 (the "Offer to Purchase"). Capitalised terms used in this announcement, but not defined, are detailed in the Offer to Purchase.

As at the Expiration Date of 11:59 p.m. EST on 1 September 2015, an aggregate principal amount of $806,474,000 of Notes had been validly tendered in the Tender Offer. The Company has decided to accept for purchase an aggregate principal amount of Notes equal to the Tender Cap of $300,000,000. Notes validly tendered for purchase pursuant to the Tender Offer will therefore be accepted on a pro rata basis with a proration factor of 0.391907, as described in the Offer to Purchase. Notes not accepted for purchase will be returned to Holders. 

The Notes have the following CUSIP/ISIN designations: CUSIP No. 01377RAB9, ISIN No. US01377RAB96 (Rule 144A) / CUSIP No. U01176AB9, ISIN No. USU01176AB97 (Reg S). 

The Purchase Price of the Notes is $1,080 per $1,000 principal amount of Notes validly tendered on or prior to the Expiration Date and accepted for purchase by the Company. All Holders of Notes accepted for purchase pursuant to the Tender Offer will also receive a cash payment representing the accrued and unpaid interest on their purchased Notes from the last applicable interest payment date for such Notes to, but excluding the Settlement Date. 

The expected Settlement Date for the Tender Offer is 4 September 2015. All payments will be made on the Settlement Date. Notes repurchased by the Company pursuant to the Tender Offer will be cancelled. The aggregate principal amount of the Notes outstanding following the settlement of the Tender Offer will be $700,000,000. 

The Company reserves the right to continue to repurchase Notes, off-market or in the market, from time to time. 

The Dealer Managers are: Citigroup Global Markets Limited, Citigroup Centre, Canada Square, Canary Wharf, London E14 5LB, United Kingdom, Attention: Liability Management Group, Telephone: +44 20 7986 8969, E-mail: liabilitymanagement.europe@citi.com; and Credit Suisse Securities (Europe) Limited, One Cabot Square, London E14 4QL, United Kingdom, Attention: Liability Management Group, Telephone: +44 20 7883 8763, E-mail: liability.management@credit-suisse.com. 

The Tender Agent is: Citibank N.A., London Branch, Citigroup Centre, Canada Square, Canary Wharf, London E14 5LB, Telephone: +44 20 7508 3867, Email: exchange.gats@citi.com. 

Holders with questions about the Tender Offer should contact the Dealer Managers or the Tender Agent.

Disclaimer

This announcement must be read in conjunction with the Offer to Purchase. No offer or invitation to acquire or sell any securities is being made pursuant to this announcement. The distribution of this announcement and the Offer to Purchase in certain jurisdictions may be restricted by law. Persons into whose possession this announcement or the Offer to Purchase comes are required by the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restriction.

The Company has not filed this announcement or the Offer to Purchase with, and they have not been reviewed by, any federal or state securities commission or regulatory authority of any country. No authority has passed upon the accuracy or adequacy of the Tender Offer, and it is unlawful and may be a criminal offense to make any representation to the contrary.